Risk factors of venous thromboembolism in postmenopausal women without neoplasms and establishment of the prediction model

Jingrong NIU; Lijin ZHANG; Wenshuang YANG

doi:10.16016/j.1000-5404.202005211

您当前的位置：

首页 >

文章列表页 >

Risk factors of venous thromboembolism in postmenopausal women without neoplasms and establishment of the prediction model

Clinical Medicine | 更新时间：2026-01-09

- Risk factors of venous thromboembolism in postmenopausal women without neoplasms and establishment of the prediction model
- Journal of Third Military Medical University Vol. 42, Issue 22, Pages: 2224-2230(2020)
- 作者机构：
  
  100020 北京市, 首都医科大学附属北京朝阳医院血管外科
- 作者简介：
- 基金信息：
  
  the Research Fund of Beijing Chaoyang Hospital, Capital Medical University(201805127)
- DOI：10.16016/j.1000-5404.202005211
  CLC： R181.23;R364.15;R711.51
- Received：25 May 2020，
  
  Revised：2020-08-07，
  
  Published：30 November 2020
- 稿件说明：
移动端阅览
Jingrong NIU, Lijin ZHANG, Wenshuang YANG. Risk factors of venous thromboembolism in postmenopausal women without neoplasms and establishment of the prediction model[J]. Journal of Third Military Medical University, 2020, 42(22): 2224-2230.
DOI：

Jingrong NIU, Lijin ZHANG, Wenshuang YANG. Risk factors of venous thromboembolism in postmenopausal women without neoplasms and establishment of the prediction model[J]. Journal of Third Military Medical University, 2020, 42(22): 2224-2230. DOI： 10.16016/j.1000-5404.202005211.

摘要

目的

探究绝经期非肿瘤女性发生静脉血栓栓塞症(venous thromboembolism

VTE)的危险因素，并构建预测模型。

方法

选取2018年5月至2019年12月我科收治的268例绝经期非肿瘤女性疑似VTE的患者作为研究对象。以彩色多普勒超声确诊是否发生VTE分为VTE组(

=42)和非VTE组(

=226)。对两组的临床资料进行单因素分析和多因素Logistic回归分析，并建立预测模型，用灵敏度、特异度、ROC曲线下面积及预测正确率评价模型的预测效果。

结果

经多因素Logistic回归分析发现合并糖尿病(

值=15.318，95%

=6.563~74.275，

=0.036)、Caprini评分≥5分(

值=7.737，95%

=2.459~13.168，

=0.012)、D-二聚体

0.5 mg/L(

值=10.602，95%

=3.767~17.706，

=0.000)、三酰甘油(Triglyceride，TG)

1.7 mmol/L(

值=2.651，95%

=1.238~5.357，

=0.002)、黄体生成素(Luteinizing Hormone，LH)

52.3 U/L(

值=1.539，95%

=1.127~4.673，

=0.031)、雌二醇(Estrodiol，E

)

30 nmol/L(

=1.164，95%

=1.064~2.058，

=0.047)为绝经期非肿瘤女性发生VTE的危险因素。根据危险因素得出预测模型:Prob=1/(e

^-Y

)，Y=36.578-2.729×合并糖尿病-2.046×Caprini评分-2.361×血清D-二聚体-0.975×血清TG-0.431×血清LH-0.152×血清E

。模型经ROC曲线分析得AUC为0.915，灵敏度为90.30%，特异度为94.10%。通过验证得出模型预测的正确率为88.43%。

结论

合并糖尿病、Caprini评分≥5分、D-二聚体

0.5 mg/L、TG

1.7 mmol/L、LH

52.3 U/L、E

30 nmol/L是绝经期非肿瘤女性发生VTE的危险因素，根据危险因素建立预测模型能有效评估绝经期非肿瘤女性VTE的发生风险。

Abstract

Objective

To explore the risk factors and establish a prediction model of venous thromboembolism (VTE) in postmenopausal women without neoplasms.

Methods

A total of 268 postmenopausal women w

ith suspected VTE without neoplasms admitted to our department from May 2018 to December 2019 were divided into VTE group (

=42) and non-VTE group (

=226) based on color Doppler ultrasound findings. The clinical data of the 2 groups were analyzed by univariate and multivariate logistic regression analysis to identify the risk factors of VTE. The prediction model was established based on the identified risk factors and evaluated for its sensitivity

specificity

area under the receiver-operating characteristic (ROC) curve

and the prediction accuracy.

Results

Multivariate logistic regression analysis identified diabetes mellitus (

=15.318

95%

: 6.563-74.275

=0.036)

a Caprini score ≥5 (

=7.737

95%

: 2.459-13.168

=0.012)

D-dimer

0.5 mg/L (

=10.602

95%

: 3.767-17.706

=0.000)

triglycerides (TG)

1.7 mmol/L (

=2.651

95%

: 1.238-5.357

=0.002)

luteinizing hormone (LH)

52.3 IU/L (

=1.539

95%

: 1.127-4.673

=0.031)

and estradiol (E

)

30 nmol/L (

=1.164

95%

: 1.064-2.058

=0.047) as the risk factors for VTE in postmenopausal women without neoplasms. Based on these risk factors

the prediction model for VTS was derived: Prob=1/(e^

-Y

)

where Y=36.578-2.729×combined diabetes-2.046×Caprini score-2.361×serum D-dimer-0.975×serum TG-0.431×serum LH-0.152×serum E

. ROC curve analysis showed that this prediction model had an AUC of 0.915 with a sensitivity of 90.30% and a specificity of 94.10%. The verification results showed that this model had an accuracy of 88.43% for predicting VTE in postmenopausal women without neoplasms.

Conclusion

Diabetes

a Caprini sc

ore ≥5

a D-dimer level

0.5 mg/L

a TG level

1.7 mmol/L

a LH level

52.3 U/L

and an E

level

30 nmol/L are all risk factors of VTE in postmenopausal women without neoplasms. The predictive model constructed based on these risk factors can effectively assess the risk of VTE in these women.

关键词

Keywords

references

李灿, 谢杨丽, 苏楠, 等.重庆地区围绝经期与绝经后妇女骨密度及身体成分相关指标分析[J].中国骨质疏松杂志, 2019, 25(12): 1765-1781. DOI: 10.3969/j.issn.1006-7108.2019.12.020.

LI C, XIE Y L, SU N, et al . Analysis of related indexes of bone mineral density and body composition of women in perimenopause and postmenopause in Chongqing area[J ] . Chin J Osteopor, 2019, 25(12): 1765-1781. DOI: 10.3969/j.issn.1006-7108.2019.12.020.

张晶, 刘梅林.绝经激素治疗与心血管疾病防治[J].中华心血管病杂志, 2020, 48(03): 259-262. DOI: 10.3760/cma.j.cn112148-20190815-00495.

ZHANG J, LIU M L. Menopausal hormone therapy and cardiovascular disease prevention and treatment[J]. Chin J Cardiol, 2020, 48(03): 259-262. DOI: 10.3760/cma.j.cn112148-20190815-00495.

SCARABIN P Y.Progestogens and venous thromboembolism in menopausal women: an updated oral versus transdermal estrogen meta-analysis[J]. Climacteric, 2018, 21(4): 341-345. DOI: 10.1080/13697137.2018.1446931.

OLIVER-WILLIAMS C, GLISIC M, SHAHZAD S, et al . The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review[J ] . Hum Reprod Update, 2019, 25(2): 257-271. DOI: 10.1093/humupd/dmy039.

袁光华.超声诊断基础与临床检查规范[M].北京:科学技术文献出版社, 2005: 243-252.

YUAN G H. Ultrasound diagnosis basic and clinical examination specifications[M]. Beijing: Science and Technology Literature Press, 2005: 243-252.

史惠蓉, 李雪茹, 贾艳艳.绝经激素治疗与动静脉血栓栓塞性疾病[J].中国实用妇科与产科杂志, 2020, 36(03): 224-227. DOI: 10.19538/j.fk2020030110.

SHI H R, LI X R, JIA Y Y. Menopausal hormone therapy and arteriovenous thromboembolic diseases[J]. Acta Metallurgica Sinica, 2020, 36(03): 224-227. DOI: 10.19538/j.fk2020030110.

邱荣飞, 刘玫鸽.维生素E对围绝经期妇女深静脉血栓形成的预防效果[J].中国老年学, 2010, 30(08): 1046-1048. DOI: 10.3969/j.issn.1005-9202.2010.08.012.

QIU R F, LIU M G. The preventive effect of vitamin E on deep vein thrombosis inperimenopausal women[J]. Chin J Gerontol, 2010, 30(8): 1046-1048. DOI: 10.3969/j.issn.1005-9202.2010.08.012.

SHEN L, SONG L, LI H, et al . Association between earlier age at natural menopause and risk of diabetes in middle-aged and older Chinese women:The Dongfeng-Tongji cohort study[J ] . Diabetes Metab, 2017, 43(4): 345-350. DOI: 10.1016/j.diabet.2016.12.011.

LEBLANC E S, KAPPHAHN K, HEDLIN H, et al . Reproductive history and risk of type 2 diabetes mellitus in postmenopausal women: findings from the Women's Health Initiative[J ] . Menopause, 2017, 24(1): 64-72. DOI: 10.1097/gme.0000000000000714.

MAUVAIS-JARVIS F, MANSON J E, STEVENSON J C, et al . Menopausal hormone therapy and type 2 diabetes prevention: evidence, mechanisms, and clinical implications[J ] . Endocr Rev, 2017, 38(3): 173-188. DOI: 10.1210/er.2016-1146.

文进博, 杨松, 赵祥海, 等.绝经状态对空腹血糖受损及2型糖尿病发病影响的研究[J].中华预防医学杂志, 2017, 51(8): 728-733. DOI: 10.3760/cma.j.issn.0253-9624.2017.08.013.

WEN J B, YANG S, ZHAO X H, et al . Effect of menopausal status on onset of impaired fasting glucose and type 2 diabetes mellitus[J ] . Chin J Prev Med, 2017, 51(8): 728-733. DOI: 10.3760/cma.j.issn.0253-9624.2017.08.013.

尹利军, 王晓慧.雄激素及其受体在肥胖、肥胖相关疾病及糖脂代谢紊乱中的作用[J].生理学报, 2018, 70(3): 319-328. DOI: 10.13294/j.aps.2018.0018.

YIN L J, WANG X H. Research advance in the effects of androgen and its receptor on the development of obesity, obesity-related diseases and disorders of glucose and lipid metabolism[J]. Acta Physiol Sin, 2018, 70(3): 319-328. DOI: 10.13294/j.aps.2018.0018.

TANAKA S, HISHIKI M, OGASAWARA J, et al . The deterioration of the glycemic profile during hormone replacement therapy in a patient with fulminant type 1 diabetes[J ] . Intern Med, 2017, 56(5): 531-534. DOI: 10.2169/internalmedicine.56.7663.

李钱玲, 甘秀妮, 李源, 等. Autar量表与Caprini评估模型对肿瘤患者PICC相关静脉血栓形成预测效果的对比研究[J].护理学报, 2019, 26(22): 1-5. DOI: 10.16460/j.issn1008-9969.2019.22.001.

LI Q L, GAN X N, LI Y, et al . Comparison of predictivepower for PICC-related venous thromboembolism among cancer patients ofautar DVT risk assessment scale and caprini risk assessment scale[J ] . J Nurs China, 2019, 26(22): 1-5. DOI: 10.16460/j.issn1008-9969.2019.22.001.

李巧莲, 田亮, 付天英, 等. Caprini风险评估模型预测腹部手术患者发生VTE有效性分析[J].华北理工大学学报(医学版), 2019, 21(02): 102-110. DOI: 10.19539/j.cnki.2095-2694.2019.02.004.

LI Q L, TIAN L, FU T Y, et al . Effectiveness analysis ofCaprini risk assessment model for predicting the occurrence of VTE in pa tients undergoing abdominal surgery[J ] . J North China Univ Tech (Med Ed), 2019, 21(02): 102-110. DOI: 10.19539/j.cnki.2095-2694.2019.02.004.

周建西, 代俊利, 宋冀.Caprini血栓风险评估模型预测肺癌患者深静脉血栓形成风险的有效性研究[J].大连医科大学学报, 2020, 42(01): 21-26. DOI: 10.11724/jdmu.2020.01.05.

ZHOU J X, DAI J L, SONG J. Effectiveness of Caprini thrombosis risk assessment model in predicting the risk of deep vein thrombosis in patients with lung cancer[J]. J Dalian Med Univ, 2020, 42(01): 21-26. DOI: 10.11724/jdmu.2020.01.05.jdmu.2020.01.05.

李汉平, 麦金秀, 黎雪梅, 等.Caprini风险评估模型联合D-二聚体在子宫切除术围手术期静脉血栓栓塞性疾病中的诊断价值[J].中国医师进修杂志, 2020, 43(7): 639-642. DOI:10.3760/cma.j.cn115455-20200115-00069.

LI H P, MAI J X, LI X M, et al . Diagnostic value ofCaprini risk assessment model combined with D-dimer in perioperative hysterectomy for venous thromboembolic diseases[J ] . Chin J Postgrad Med, 2020, 43(7): 639-642. DOI: 10.3760/cma.j.cn115455-20200115-00069.

RAHIMINEJAD M, RASTOGI A, PRABHUDESAI S, et al . Evaluating the use of a negative D-dimer and modified low wells score in excluding above knee deep venous thrombosis in an outpatient population, assessing need for diagnostic ultrasound[J ] . ISRN Radiol, 2014, 2014: 1-5. DOI: 10.1155/2014/519875.

中华医学会外科学分会血管外科血组.深静脉血栓形成的诊断和治疗指南(第三版)[J].中华血管外科杂志, 2017, 04: 201-208. DOI: 10.3760.cma.j.issn.2096-1863.2017.04.002.

Group ofVascular Surgery, Chinese Medical Association Surgery Branch. Guidelines for the diagnosis and treatment of deep vein thrombosis (third edition)[J]. Chin J Vasc Surg, 2017, 04: 201-208. DOI: 10.3760.cma.j.issn.2096-1863.2017.04.002.

AUGEREAU P, PATSOURIS A, BOURBOULOUX E, et al .Hormonoresistance in advanced breast cancer: a new revolution in endocrine therapy[J ] . Ther Adv Med Oncol, 2017, 9(5): 335-346. DOI: 10.1177/1758834017693195.

苗芸, 傅玉娟, 宋芳霞, 等.雌激素替代疗法对内分泌失调女性内分泌轴功能的影响[J].现代生物医学进展, 2019, 19(15): 2941-2944;2924.DOI: 10.13241/j.cnki.pmb.2019.15.032.

MIAO Y, FU Y J, SONG F X, et al . Effects of estrogen replacement therapy on the endocrine axis function of endocrine disorder women[J ] . Prog Mod Biomed, 2019, 19(15): 2941-2944;2924. DOI: 10.13241/j.cnki.pmb.2019.15.032

聂广宁, 杨洪艳, 刘建, 等.围绝经期女性血脂变化的多中心临床流行病学调查[J].中国妇幼保健, 2017, 32(24): 6208-6211.

NIE G N, YANG H Y, LIU J, et al . A multi-center clinical epidemiological investigation on changes of blood lipids in perimenopausal women[J ] . Matern Child Heal Care China, 2017, 32(24): 6208-6211.

ESCALANTE C, MORA S, BOLAÑOS L. Hormone replacement therapy reduces lipid oxidation directly at the arterial wall: a possible link to estrogens'cardioprotective effect through atherosclerosis prevention[J]. J Mid-life Health, 2017, 8(1): 11. DOI: 10.4103/0976-7800.201967.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Incidence and risk factors of acute renal injury after Stanford type A aortic dissections

Predictive value and risk factors of embryo implantation site for placenta previa

Construction and validation of a risk prediction model for lean metabolic dysfunction-associated steatotic liver disease

Risk factors for biochemical recurrence of prostate cancer after radical prostatectomy

Construction of a risk prediction model for proteinuria progression in diabetic nephropathy by classification tree

Related Author

XU Xiao

LI Xiaodong

WEN Jing

NING Jiaolin

KUANG Na

HE Wenjiao

XIONG Xi

CHEN Zhengqiong

Related Institution

Department of Anesthesiology， First Affiliated Hospital， Army Medical University （Third Military Medical University）

Department of Obstetrics and Gynecology， Second Affiliated Hospital， Army Medical University （Third Military Medical University）

Department of Gastroenterology， First Affiliated Hospital， Army Medical University （Third Military Medical University）

School of International Economics and Trade, University of International Business and Economics

Department of Health Statistics， College of Military Preventive Medicine, University of International Business and Economics

⁰